Intravitreal Ranibizumab Injection for ROP in Neonates

Intravitreal ranibizumab has been extensively studied for the treatment of retinopathy of prematurity (ROP), but the actual injection technique is different for neonates than for other age groups, owing to smaller globe diameter, bigger lens volume, and the absence of pars plana. In this video, Dr. Rahul Bhatia and colleagues provide step-by-step instructions for injecting intravitreal ranibizumab in neonates.

Financial Disclosures: Dr. Rahul Bhatia discloses no financial relationships. Dr. Devesh Kumawat discloses no financial relationships. Dr. Sarita Beri discloses no financial relationships.